Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Feltwood | 2024 | Non Equity Assistance | Undisclosed | Zaragoza |
| Eversens | 2024 | Debt Financing | Undisclosed | Noáin |
| HEPHAISTOS-Pharma | 2024 | Seed | $4.9M | Orsay |
| Tiamat | 2024 | Series Unknown | Undisclosed | Amiens |
| Qlayers | 2024 | Private Equity | Undisclosed | Delft |
| Orbital Eye | 2023 | Series Unknown | $2.2M | Delft |
| NutriLeads | 2023 | Series C | $4.9M | Wageningen |
| GRZ Technologies | 2023 | Series Unknown | Undisclosed | Sion |
| Kamleon | 2023 | Pre-Seed | $1.1M | Barcelona |
| In Ovo | 2023 | Debt Financing | $42.5M | Leiden |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Feltwood | Non Equity Assistance | Undisclosed | Zaragoza, Spain |
| 177 | Eversens | Debt Financing | Undisclosed | Noáin, Spain |
| 178 | HEPHAISTOS-Pharma | Seed | $4.9M | Orsay, France |
| 179 | Tiamat | Series Unknown | Undisclosed | Amiens, France |
| 180 | Qlayers | Private Equity | Undisclosed | Delft, The Netherlands |
| 181 | Orbital Eye | Series Unknown | $2.2M | Delft, The Netherlands |
| 182 | NutriLeads | Series C | $4.9M | Wageningen, The Netherlands |
| 183 | GRZ Technologies | Series Unknown | Undisclosed | Sion, Switzerland |
| 184 | Kamleon | Pre-Seed | $1.1M | Barcelona, Spain |
| 185 | In Ovo | Debt Financing | $42.5M | Leiden, The Netherlands |
Feltwood is a Spanish start-up that has developed an innovative process to manufacture ecological industrial materials.
Eversens is a company specializing in the design, development, and manufacturing of non-invasive clinical systems.
Hephaistos Pharma is a biotech company developing oncology treatments.
Tiamat designs, develops, and produces innovative solutions for energy storage applications.
Qlayers is developing hardware that creates microstructures on large surfaces.
Orbital Eye is an infrastructure management company that monitors and inspects transmission pipelines, roads, railways, and powerlines.
NutriLeads is a biotechnology company that develops and supplies plant-based, precision prebiotic fibers that improve human health.
GRZ Technologies is a company active in the field of renewable energy storage.
Kamleon is a science-based early-stage company.
In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry.
Gpa Innova design and develops machinery for metal finishing.
Life Length is a biotechnology company.
Sensefinity is provides supply-chains using AI and Blockchain.
Airmee provides a last mile delivery solution built on research based technology and leading the transition to sustainable logistics.
Cambrian Intelligence is building a teleoperation interface to intuitively control robots at a distance with hand.
Eye-tracking wearable & smart platforms empowering connectivity between patients with communication difficulties, families and medical teams
Q-Bot is a robotics company that develops intelligent tools for a wide range of industries and applications.
SonicEdge is developing a game changing speaker, bringing true to life sound in earphones and beyond
Develops line-powered monitoring solutions to optimize and enhance the resiliency of overhead power lines.
Trisol Medical develops and manufactures medical devices.
Appsilon Enterprise is a deep tech company that recreates the earth's process to grow single crystalline diamonds in the lab.
Leaf Space wants to simplify the access to Space for microsatellites’ operators.
Picosats is a developer of telecommunication systems for cubesats.
PMD Solutions is a medical device company developing novel CE marked respiratory diagnostic wearables for the hospital and home market.
Pollen Robotics develops humanoid service robots specialized in the interaction and manipulation of objects.
EISMEA has invested in 514 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Health Care, Medical, Biotechnology, Artificial Intelligence (AI), Software. The firm invests across 59 different industry categories.
Among tracked funding rounds, In Ovo received $42.5M in a Debt Financing round. EISMEA's total known invested capital is $1.0B.
EISMEA's average investment size is $4.1M across its portfolio of 514 companies.
Recent EISMEA portfolio additions include Feltwood, Eversens, HEPHAISTOS-Pharma, Tiamat, Qlayers. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors